US 11,950,923 B2
Systems, methods and apparatuses for providing bioelectronic neurocode-based therapies to mammals
Eleanor Schuler, Albuquerque, NM (US); Luis M. Ortiz, Albuquerque, NM (US); and Kermit D. Lopez, Albuquerque, NM (US)
Assigned to Electroceuticals, LLC, Albuquerque, NM (US)
Filed by ELECTROCEUTICALS, LLC, Albuquerque, NM (US)
Filed on Jul. 28, 2021, as Appl. No. 17/387,286.
Application 17/387,286 is a continuation of application No. 15/179,113, filed on Jun. 10, 2016, granted, now 11,154,238.
Claims priority of provisional application 62/202,286, filed on Aug. 7, 2015.
Prior Publication US 2021/0353223 A1, Nov. 18, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A01K 29/00 (2006.01); A61B 5/07 (2006.01); G16H 40/67 (2018.01); H04L 67/12 (2022.01)
CPC A61B 5/4836 (2013.01) [A01K 29/005 (2013.01); A61B 5/0002 (2013.01); A61B 5/076 (2013.01); G16H 40/67 (2018.01); H04L 67/12 (2013.01); A61B 2503/40 (2013.01)] 11 Claims
OG exemplary drawing
 
1. A bioelectronic medical system for treating a medical condition, comprising:
a mammal implanted controller (MIC) implantable within a mammal to monitor bioelectronic signals indicating a health condition of the mammal, the MIC further including a probe connectable to a target organ or a region within the mammal and associated with at least one of: a sensor, a neurocode treatment module, and a communication module;
at least one of: a mobile device and a resident treatment pod external to and associated with the mammal and adapted to communicate with the MIC;
a remote server adapted to receive recorded data representing the bioelectronics signals from the MIC over a digital data communication network from at least one of the mobile device and the resident treatment pod associated with the mammal and communicating with the MIC;
wherein the remote server evaluates the bioelectronics signals and in response provides neurocoded treatment signals to cause a change in a biological function of an organ of the mammal through at least one of the mobile device and the resident treatment pod for further transmission to the MIC, wherein a medical condition of the mammal is treated via administration of the neurocoded treatment signals to the mammal to cause the change in the biological function of the organ of the mammal by the MIC and wherein the MIC and remote server engage in ongoing analysis of the bioelectronics signals.